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Asphyxiating Thoracic Dysplasia (ATD) ((MIM 208500,
MIM 6112633, MIM 613091, MIM 61819, MIM614376)
belongs to the short rib polydactyly group and is charac-
terized by a long and narrow thorax, short long bones and
trident acetabular roof. Polydactyly, retinal degeneration,
cystic renal and liver diseases have been occasionally
reported. Today, mutations in IFT80 (MIM 611177),
DYNC2H1 (MIM 603297), TCC21B (MIM 612014) and
WDR19 (MIM 608151) genes have been reported in ATD.
Through a national grant (PHRC, AOM 06031), we have
collected 55 ATD cases including 29 fetuses issued from
42 families who benefit the combined approach of deep
phenotyping and molecular screening of IFT80 and
DYNC2H1. The series included 26 alive cases ranging in
age from 6 months to 36 years. Respiratory treatment was
needed in 46%, including positive pression respiration, and
invasive or non-invasive ventilation. Cystic renal and liver
diseases occur in 16% of cases; whereas retinal degenera-
tion was present in 40 % cases aged more than 2 years
(6/15). The molecular screening allowed us to detect
DYNC2H1 mutations in 63% and IFT80 mutations in 6%.
In 6 cases, only one heterozygote mutation in either IFT80
or DYNC2H1 was identified. Finally, the two genes were
excluded in 31% cases. These preliminary results empha-
size that DYNC2H1 is the major gene responsible for
ATD. The presence of only one mutation (27% of mutated
cases) may suggest a digenic diallelic inheritance. Ongoing
studies will hopefully lead to the identification of other
disease genes.
Published: 16 November 2012
doi:10.1186/2046-2530-1-S1-O4
Cite this article as: Cormier-Daire et al.: Asphyxiating Thoracic Dysplasia:
clinical and molecular review of 42 families. Cilia 2012 1(Suppl 1):O4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: valerie.cormier-daire@inserm.fr
Département de Génétique, INSERM U781, Hôpital Necker Enfants Malades,
France
Cormier-Daire et al. Cilia 2012, 1(Suppl 1):O4
http://www.ciliajournal.com/content/1/S1/O4
© 2012 Cormier-Daire et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
